Fresh Recalls

FDAClass I · Drug · Recall D-0788-2026 · Recalled August 26, 2026

Morphine Sulfate Injection recall — Fresenius Kabi USA, LLC

Agency report date: August 26, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Morphine Sulfate Injection
Company / brand
Fresenius Kabi USA
Lot / serial / date codes
Lot #: 6402820, Exp. Date 12/2028
Distribution
Nationwide within the USA.
Agency product description and boundaries

Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class I: most serious — reasonable probability of serious health consequences or death.

Affected product: Morphine Sulfate Injection recall status

3. Open the official notice or contact

Official recall ID
D-0788-2026
Brand
All Fresenius Kabi USA recalls
Classification
Class I
Units affected
625500 syringes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Lake Zurich, IL, United States
Firm address
3 Corporate Dr, 60047-8930

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 6402820, Exp. Date 12/2028
Distribution
Nationwide within the USA.
Firm notified the public via
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
FDA event ID
99533
Recall initiated
August 4, 2026
FDA classified
August 24, 2026
FDA report date
August 26, 2026

More Fresenius Kabi USA recalls

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page